BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
BioCryst Pharmaceuticals, Inc. (BCRX)
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
biocryst.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Orlideo Revenue: $601.8 million for full year 2025, up 38% year-over-year, 43% excluding European business. Non-GAAP Total Revenue Growth: Increased 45% year-over-year in 2025. Non-GAAP Operating Profit: $214 million, an increase of 198% year-over-year. Sales and Marketing Expenses: $144 million on a non-GAAP basis for 2025. Cash and Investments: $337.5 million at year-end 2025. 2026 Orlideo Revenue Guidance: Expected between $625 million and $645 million. 2026 Non-GAAP Operating Expenses Guidance: Expected between $450 million and $470 million. Warning! GuruFocus has detected 4 Warning Signs with BCRX. Is BCRX fairly valued? Test your thesis with our free DCF calculator. Release Date: February 26, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points BioCryst Pharmaceuticals Inc ( NASDAQ:BCRX ) reported a strong Orlideo revenue of $601.8 million for 2
Show less
Read more
Impact Snapshot
Event Time:
BCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCRX alerts
High impacting BioCryst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
BCRX
News
- Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]Yahoo! Finance
- BioCryst Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- BioCryst Reports Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Are BioCryst Pharmaceuticals (BCRX) Shares Offering Value After Recent Price Rebound [Yahoo! Finance]Yahoo! Finance
- BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.MarketBeat
BCRX
Earnings
- 2/26/26 - Beat
BCRX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/12/26 - Form SCHEDULE
- BCRX's page on the SEC website